LSE: AVAP
31 May 2013
AVATION PLC
(the "Company")
Open Offer - Directors' Dealings
Further to the Company's announcement on 23 May 2013 in relation to the allotment of 4,337,987 new ordinary
shares in the capital of the Company at a price of 60 pence per share (the New Shares), the Company
announces that it has received the following disclosures of directors' dealings as part of the Open Offer:
- Robert Jeffries Chatfield (and entities in which he is interested) subscribed in aggregate for
1,135,365 New Shares, bringing his total direct and indirect holdings in the Company to 8,235,366 being
16.87% of the enlarged issued share capital of the Company.
- Roderick Douglas Mahoney subscribed for 18,138 New Shares, bringing his total direct and indirect
holdings in the Company to 158,138 being 0.32% of the enlarged issued share capital of the Company.
--- ENDS ---
ENQUIRIES
Avation PLC:
Jeff Chatfield (Executive Chairman) +65 9735 4151
Liberum Capital Limited:
Chris Bowman / Richard Bootle +44 203 100 2222
W H Ireland Limited:
James Joyce +44 207 220 1666
Blythe Weigh Communications
Tim Blythe, Rob Kellner, Eleanor Parry +44 20 7138 3204
Avation plc
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.